Predicting Endoleaks Following Endovascular Aortic Aneurysm Repair Using 18F-Sodium Fluoride

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

102 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-01

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to describe Sodium Fluoride uptake (using Positron Emission Tomography-Computed Tomography - PET-CT) following Endovascular Aneurysm Repair (EVAR) and to determine whether Sodium Fluoride PET-CT can predict the development of endoleaks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Prospective Study: the Value of Using iFlow and PBV in the Endovascular Treatment of Infrapopliteal Arterial Occlusive Diseases

NCT03248323

Arterial Occlusive Diseases

UNKNOWN

Rt Ventricular Substrate Metabolism as a Predictor of Rt Heart Failure in Patients With Pulmonary Arterial Hypertension

NCT01572077

Pulmonary Arterial Hypertension

COMPLETED NA

Screening for Occult Malignancy in Patients with Unprovoked Venous Thromboembolism

NCT04304651

Embolism and Thrombosis

RECRUITING NA

CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients

NCT03083093

CTEPH Pulmonary Embolism Early Diagnosis

COMPLETED

A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

NCT05098769

Pulmonary Embolism and Thrombosis Deterioration, Clinical

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Abdominal aortic aneurysms are a leading cause of death in the United Kingdom. Surveillance programmes and pre-emptive surgical repair are lifesaving. Traditional open surgical repair is associated with major perioperative morbidity and mortality and there has been a move towards minimally invasive Endovascular Aneurysm Repair (EVAR), which reduces these early risks. However, the cost effectiveness and long-term clinical effectiveness of EVAR is undermined by concerns of durability due to the development of endoleaks and late aneurysm rupture secondary to progression of native aortic aneurysm disease and stent graft failure. It has previously been demonstrated that 18F-Sodium Fluoride Positron Emission Tomography can predict progression of aneurysm disease and is associated with greater rates of abdominal aortic aneurysm expansion and the future risk of rupture or surgical repair.

The investigators here wish to examine whether 18F-Sodium Fluoride on Positron Emission Tomography uptake (i) is increased in patients with endoleaks or related complications, (ii) can prospectively predict the likelihood of developing endoleaks in patients undergoing EVAR, and (ii) is a feasible approach to select patients for EVAR with a reduced future risk of stent graft failure and re-intervention. The investigators believe that there is a compelling scientific rationale for this approach with major translational potential to better select subgroups of patients for EVAR and ultimately improve their outcome.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Aortic Aneurysm Endoleak Stent-Graft Endoleak

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Endoleak Group

Participants with a previous Endovascular Aneurysm Repair (EVAR) who have developed an endoleak

18F Sodium Fluoride Positron Emission Tomography / Computed Tomography

Intervention Type DIAGNOSTIC_TEST

PET scan using the 18F-Sodium Fluoride radiotracer followed by an attenuation correction CT scan

CT Aortic Angiogram

Intervention Type DIAGNOSTIC_TEST

CT scan to assess aortic morphology and contextualise PET scan

No Endoleak Group

Participants with a previous Endovascular Aneurysm Repair (EVAR) who have not developed an endoleak

18F Sodium Fluoride Positron Emission Tomography / Computed Tomography

Intervention Type DIAGNOSTIC_TEST

PET scan using the 18F-Sodium Fluoride radiotracer followed by an attenuation correction CT scan

CT Aortic Angiogram

Intervention Type DIAGNOSTIC_TEST

CT scan to assess aortic morphology and contextualise PET scan

Pre-EVAR Group

Participants who have an abdominal aortic aneurysm and who are undergoing an Endovascular Aneurysm Repair as standard of care

18F Sodium Fluoride Positron Emission Tomography / Computed Tomography

Intervention Type DIAGNOSTIC_TEST

PET scan using the 18F-Sodium Fluoride radiotracer followed by an attenuation correction CT scan

12-month CT Aortic Angiogram

Intervention Type DIAGNOSTIC_TEST

CT scan to assess aortic morphology and the stent graft

24-month review

Intervention Type OTHER

This will consist of a telephone consultation with the study participant and review of electronic clinical records

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

18F Sodium Fluoride Positron Emission Tomography / Computed Tomography

PET scan using the 18F-Sodium Fluoride radiotracer followed by an attenuation correction CT scan

Intervention Type DIAGNOSTIC_TEST

CT Aortic Angiogram

CT scan to assess aortic morphology and contextualise PET scan

Intervention Type DIAGNOSTIC_TEST

12-month CT Aortic Angiogram

CT scan to assess aortic morphology and the stent graft

Intervention Type DIAGNOSTIC_TEST

24-month review

This will consist of a telephone consultation with the study participant and review of electronic clinical records

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of AAA as defined by the European Society of Vascular Surgery guidelines on the management of aorto-iliac artery aneurysms, and having undergone endovascular repair within the recommended Instructions For Use (IFU) by the manufacturer. \['Endoleak' and 'No Endoleak groups only\]
* Complication will be defined as any type of endoleak or stent graft migration \['Endoleak' group only\].
* A diagnosis of AAA requiring endovascular repair OR a diagnosis of juxtarenal AAA requiring fenestrated endovascular aneurysm repair as defined by the European Society of Vascular surgery guidelines on the management of aorto-iliac artery aneurysms and planned EVAR or fenestrated EVAR surgery. \['pre-EVAR' group only\]
* Minimum age: 50 years. No maximum age.
* Retain capacity for informed consent

Exclusion Criteria

* The inability of patients to undergo PET/CT scanning
* Chronic kidney disease (eGFR ≤ 30 mL/min/1.73 m2)
* Major or untreated cancer
* Pregnancy
* Allergy or contra-indication to iodinated contrast
* Inability or unwillingness to give informed consent
* Life-expectancy of less than two years
* Known history of connective tissue disease

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No